OUTLOOK THERAPEUTICS Trademark

Trademark Overview

On Monday, June 27, 2022, a trademark application was filed for OUTLOOK THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OUTLOOK THERAPEUTICS trademark a serial number of 97478024. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, April 10, 2025. This trademark is owned by Outlook Therapeutics, Inc.. The OUTLOOK THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease
outlook therapeutics

General Information

Serial Number97478024
Word MarkOUTLOOK THERAPEUTICS
Filing DateMonday, June 27, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, April 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2023

Trademark Statements

Goods and ServicesPharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 14, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOutlook Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIselin, NJ 08830
Party NameOutlook Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIselin, NJ 08830

Trademark Events

Event DateEvent Description
Wednesday, April 12, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, June 30, 2022NEW APPLICATION ENTERED
Thursday, July 14, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 10, 2023ASSIGNED TO EXAMINER
Wednesday, April 12, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 12, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 12, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, April 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 16, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 16, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 9, 2024SOU EXTENSION 1 FILED
Tuesday, January 9, 2024SOU EXTENSION 1 GRANTED
Friday, June 28, 2024SOU TEAS EXTENSION RECEIVED
Friday, June 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 28, 2024SOU EXTENSION 2 FILED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 28, 2024SOU EXTENSION 2 GRANTED
Monday, December 23, 2024SOU TEAS EXTENSION RECEIVED
Monday, December 23, 2024SOU EXTENSION 3 FILED
Tuesday, December 24, 2024SOU EXTENSION 3 GRANTED
Wednesday, March 19, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 19, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 19, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, March 19, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 10, 2025SOU TEAS EXTENSION RECEIVED
Thursday, April 10, 2025SOU EXTENSION 4 FILED
Thursday, April 10, 2025SOU EXTENSION 4 GRANTED
Friday, April 11, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 14, 2025SOU TEAS EXTENSION RECEIVED

Related Keywords

therapeutics outlook retinal disease treatment drugs namely ophthalmic pharmaceuticals